EVIAGENICS
Paris
About EVIAGENICS
EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2011)
- Website: eviagenics.com
- Phone: 33 1 55 42 15 75
Industries & Categories
Biotechnology, Manufacturing, Personal Health, Pharmaceutical
Canonical: https://fsome.com/organization/eviagenics-2316756 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.